Evaluation and management of alveolitis and interstitial lung disease in scleroderma

In the fibrosing alveolitis of systemic sclerosis, treatment decisions depend on prognostic evaluation, which continues to excite considerable interest and debate. Advances in the staging of fibrosing alveolitis of systemic sclerosis and recent therapeutic studies are discussed in this review.The decision about whether to start treatment is often the most difficult clinical challenge, because many patients have limited pulmonary fibrosis that...